Table S2. Genes found to be differentially expressed in multiple studies included in scenario 1 (involved LN versus primary breast tumour). (PDF 18 kb
Classification of genes based on the expression levels. A table showing how the gene expression leve...
Figure S1. Bioinformatics analysis of differential expressed coding genes (A) KEGG pathway analysis ...
Supplementary Methods. Description of nucleic acid isolation and purification, aCGH gene expression ...
Table S1. Gene list compiled from all the studies included in scenario 1 (involved LN versus primary...
Table S5. Differentially expressed genes representing specific immune cell populations across all th...
Supplementary methods. Detailed description of tissue preparation including microtomy, de-waxing and...
Gene expression by participant and clinical characteristics from CBCS Phase 3, 2008–2013. Table S2. ...
Table S1. Clinical and pathological characteristics for eligible patients in the I-SPY cohort. Table...
Scatter plots of gene expression values between samples. A figure illustrating how similar of genes ...
Figure S2. Venn diagram of common genes number in ER-positive signatures from different platform. Co...
Table S1. Overview of clinical characteristics of the patient and tumour information stratified by t...
Table S1. Systems-level properties of cancer genes. Table S2 List of 273 publications describing can...
Tumor vs Adjacent differentially expressed genes. The full list of 164 significant genes selected fr...
Expression levels of 98 down-regulated genes and 62 up-regulated genes in the NSLN positive group. A...
Table S2. Gene distribution among the signatures. A matrix with each of all signature genes against ...
Classification of genes based on the expression levels. A table showing how the gene expression leve...
Figure S1. Bioinformatics analysis of differential expressed coding genes (A) KEGG pathway analysis ...
Supplementary Methods. Description of nucleic acid isolation and purification, aCGH gene expression ...
Table S1. Gene list compiled from all the studies included in scenario 1 (involved LN versus primary...
Table S5. Differentially expressed genes representing specific immune cell populations across all th...
Supplementary methods. Detailed description of tissue preparation including microtomy, de-waxing and...
Gene expression by participant and clinical characteristics from CBCS Phase 3, 2008–2013. Table S2. ...
Table S1. Clinical and pathological characteristics for eligible patients in the I-SPY cohort. Table...
Scatter plots of gene expression values between samples. A figure illustrating how similar of genes ...
Figure S2. Venn diagram of common genes number in ER-positive signatures from different platform. Co...
Table S1. Overview of clinical characteristics of the patient and tumour information stratified by t...
Table S1. Systems-level properties of cancer genes. Table S2 List of 273 publications describing can...
Tumor vs Adjacent differentially expressed genes. The full list of 164 significant genes selected fr...
Expression levels of 98 down-regulated genes and 62 up-regulated genes in the NSLN positive group. A...
Table S2. Gene distribution among the signatures. A matrix with each of all signature genes against ...
Classification of genes based on the expression levels. A table showing how the gene expression leve...
Figure S1. Bioinformatics analysis of differential expressed coding genes (A) KEGG pathway analysis ...
Supplementary Methods. Description of nucleic acid isolation and purification, aCGH gene expression ...
DOI
Add to ORKG